PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • Actual results may differ materially from these forward-looking statements due to a number of factors, including uncertainties relating to the initiation and completion of stages of the SB-509 clinical trials, whether the SB-509 clinical trials will validate and support safety, tolerability and efficacy of SB-509, technological challenges, Sangamo's ability to develop commercially viable products
http://www.w3.org/ns/prov#wasQuotedFrom
  • sangamo.com